Additionally, Reata will receive milestone payments upon completion of certain development and approval objectives for bardoxolone in the licensed territories.

Sandoz said it would also supply Organogenesis with milestone payments and research support, among other things.

Other milestone payments are tied to revenue goals for the drug.

Embraer would be funding the engineering, testing and tooling with milestone payments throughout the development process.

Sankyo promised to pay $10 million to Cygnus as milestone payments.

An additional $15 million in milestones was to be paid by Sankyo, therefore taking the total milestone payments up to $25 million.

Diversa, which is based in San Diego, will receive milestone payments and royalties on products they help develop.

Baxter will then provide another $60 million in research financing and milestone payments.

In addition, Pfizer will make product-based milestone payments to Myco that could exceed $30 million, if more than one drug is developed.

Glaxo had paid $22 million, plus milestone payments.